Clinical Trial Update: Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial results assessing safety and immunogenicity of the NDV-HXP-S vaccine in Thailand have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia Viral

Drugs mentioned

• NDV-HXP-S vaccine

Snippet

Sponsor: Mahidol University | Conditions: Covid-19, SARS Pneumonia | Phase 1, Phase 2 | Status: COMPLETED